Menu Back toDiscovery and Preclinical Testing Phases

Discovery and Preclinical Testing Phases


Overview

This module is part of the DIA Drug Development and Life Cycle Management eLearning Program. In the Discovery and Preclinical Testing Phases module, learners focus on how companies advance potential drug candidates through the earliest stages of research, from therapeutic target to readiness for clinical studies.

Estimated time to complete module: 1 hour

Who should attend?

This module is designed for individuals who are new to, or changing roles, in the pharmaceutical and biotech industries.   This module will also benefit professionals who work in the area of:

  • Clinical Research
  • Project Management
  • Administrative Support
  • Quality Assurance
  • Regulatory Affairs
  • Manufacturing
  • Medical Writing
  • Business Support

Learning objectives

Upon completion of this module, learners should be able to:

  • Describe discovery activities
  • Explain how toxicology studies are conducted
  • Discuss drug substance production and drug product formulation activities
  • Describe good manufacturing and laboratory practices
  • Explain how biomarkers and surrogate markers are used

Contact us